Effects of Paricalcitol and Aliskiren Combination Therapy on Experimental Diabetic Nephropathy Model in Rats

Publisher： Karger

E-ISSN： 1423-0143|39|6|581-590

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.39, Iss.6, 2014-12, pp. : 581-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pleiotropic and Renoprotective Effects of Erythropoietin Beta on Experimental Diabetic Nephropathy Model

By  

Nephron, Vol. 132, Iss. 4, 2016-03 ,pp. : 292-300

Karger

Access to resources Recommend Favorite

Cardiac and Renal Effects of Atrasentan in Combination with Enalapril and Paricalcitol in Uremic Rats

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 4, 2014-09 ,pp. : 340-352

Karger

Access to resources Recommend Favorite

Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy

By  

American Journal of Nephrology, Vol. 19, Iss. 1, 1999-03 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Functional Subtypes of Renal α1-Adrenoceptor in Spontaneously Hypertensive Rats with Streptozotocin-Induced Experimental Diabetic Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 5, 2009-10 ,pp. : 349-359

Karger

Access to resources Recommend Favorite

Beneficial Effect of Combination Therapy with an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitor on Overt Proteinuria in a Patient with Type 1 Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 529-530

Karger

Access to resources Recommend Favorite